Regulations
FDA approves J&J’s myeloma cell therapy
RegulationsFDA approves J&J’s myeloma cell therapyFDA approves J&J’s myeloma cell therapy
The US FDA has approved a CAR-T therapy developed by Johnson & Johnson and its partner Legend Biotech to treat white blood cell cancer.